Drug Shortage Report for TARO-ZOLEDRONIC ACID CONCENTRATE

Last updated on 2021-05-04 History
Report ID 138594
Drug Identification Number 02415186
Brand name TARO-ZOLEDRONIC ACID CONCENTRATE
Common or Proper name ZOLEDRONIC ACID
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 ml
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-20
Estimated end date 2021-06-11
Actual end date
Shortage status Actual shortage
Updated date 2021-05-04
Company comments
Health Canada comments
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-05-04 French Compare
v4 2021-05-04 English Compare
v3 2021-05-01 French Compare
v2 2021-05-01 English Compare
v1 2021-05-01 English Compare